Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has urged shareholders to support change by voting for their nominated directors-John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters-at the upcoming shareholder meeting. Apollo Capital, which owns approximately 3.0% of the company's common stock, expressed concerns over MediPharm's financial health, warning that the company may run out of money by November 2025. They have advised shareholders to disregard any "GREEN" proxy cards from the current management and instead support their call for board-level change to address the company's declining financial position. Shareholders are encouraged to read the detailed circular available on SEDAR+ for more information.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。